CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Initial Invasive or Conservative Strategy for Stable Coronary Disease Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes Cardio-Oncology: Vascular and Metabolic Perspectives: A Scientific Statement From the American Heart Association Plasma Ionized Calcium and Risk of Cardiovascular Disease: 106 774 Individuals from the Copenhagen General Population Study Heart Failure Outcomes With Volume-Guided Management Heart Failure and Atrial Fibrillation, Like Fire and Fury Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV Trial Impact of intravascular ultrasound on the long-term clinical outcomes in the treatment of coronary ostial lesions Adjunctive Cilostazol to Dual Antiplatelet Therapy to Enhance Mobilization of Endothelial Progenitor Cell in Patients with Acute Myocardial Infarction: A Randomized, Placebo-Controlled EPISODE Trial 6- Versus 24-Month Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents in Patients Nonresistant to Aspirin Final Results of the ITALIC Trial (Is There a Life for DES After Discontinuation of Clopidogrel)

Consensus2019 Jan 15. [Epub ahead of print]

JOURNAL:EuroIntervention. Article Link

Percutaneous Recanalization of Chronic Total Occlusions: 2019 Consensus Document from the EuroCTO Club

Galassi AR, Werner GS, Boukhris M et al. Keywords: drug-eluting stent; stable angina; Chronic coronary total occlusion

ABSTRACT


Since its inception in December 2006, the EuroCTO Club has strived to provide the framework for state-of-the-art chronictotal occlusion (CTO) percutaneous coronary intervention (PCI) in Europe and nearby regions. Among its initiatives, the EuroCTO Club has published a set of recommendations regarding the technical aspects of CTO PCI, whose last edition dates to 2012. The EuroCTO Club consensus document discusses CTO PCI clinical indications, techniques and equipment use, as well as operators/centers qualifications. Given the considerable amount of progress made by this subspecialty during the last years, there is the need for an updated document that includes data from recent clinical trials and registries, information on novel devices and techniques, and an up-to-date revision on the training requirements to approach CTO PCI. The current updated consensus document of the EuroCTO club reflects the expertise of European operators to promote the widespread application of state-of-the-art CTO PCI not only in Europe but also across neighboring communities.